19Indexed trials
mesh condition
Myasthenia Gravis
Intelligence
Myasthenia Gravis intelligence: 19 indexed trials, 9 recruiting studies, 18 sponsors across 36 countries.
9Recruiting
18Sponsors
36Countries
Leading sponsors
argenx22 recruiting
Dartmouth-Hitchcock Medical Center10 recruiting
First Affiliated Hospital, Sun Yat-Sen University10 recruiting
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta10 recruiting
Fredrik Piehl10 recruiting
HealthPartners Institute11 recruiting
Hoffmann-La Roche10 recruiting
Huashan Hospital11 recruiting
Kite, A Gilead Company11 recruiting
Beth Israel Deaconess Medical Center10 recruiting
Ming-Hsing Chang10 recruiting
Novartis Pharmaceuticals11 recruiting
Geographic activity
United States13trials
China8trials
Canada7trials
Spain6trials
Poland6trials
Italy6trials
Australia6trials
France5trials
Germany5trials
United Kingdom5trials
Belgium4trials
Japan4trials
Leading interventions
Rituximab2trials
Blood Draw1trials
Cheek swab1trials
Cladribine High Dose1trials
Cladribine Low Dose1trials
Current standard discharge educational intervention1trials
Cyclophosphamide1trials
Efgartigimod IV1trials
Efgartigimod PH20 SC1trials
Fludarabine1trials
KITE-3631trials
Light Intensity Exercise1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.